About Nuvalent, Inc. (NUVL)
Nuvalent, Inc. is a Biotechnology company operating in the Healthcare sector.
NUVL trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $96.43
- Market Cap
- $7.58B
- 52-Week High
- $113.02
- 52-Week Low
- $55.54
- Sector
- Healthcare
- Industry
- Biotechnology
$1,000 Invested in Nuvalent, Inc. (NUVL)
How much would $1,000 invested in NUVL be worth today?
What would $1,000 invested in NUVL 1 year ago be worth today?
A $1,000 investment in Nuvalent, Inc. (NUVL) in 2025 would be worth $1,237 as of November 2026, representing a +23.7% total return.
What would $1,000 invested in NUVL 3 years ago be worth today?
A $1,000 investment in Nuvalent, Inc. (NUVL) in 2023 would be worth $3,171 as of November 2026, representing a +217.1% total return.
What would $1,000 invested in NUVL at IPO be worth today?
A $1,000 investment in Nuvalent, Inc. (NUVL) at IPO would be worth $5,143 as of November 2026, representing a +414.3% total return.
Monthly Returns Heatmap
Over the past 4+ years (56 months), Nuvalent, Inc. (NUVL) has averaged a monthly return of +5.07% with a median return of +2.21%. The stock had 33 positive months (59%) and 23 negative months (41%). The best month in NUVL's history was August 2021 with a +99.6% return, while the worst was September 2021 at -38.1%. Historically, August tends to be the strongest month (averaging +21.8%), and March the weakest (-8.5%).
NUVL's longest winning streak was 6 consecutive months of gains, while its longest losing streak was 3 consecutive months of losses. The best full year was 2023 with a cumulative return of +104.5%, and the worst was 2024 at 14.7%.
Annual Returns
Over 5 years of trading history, Nuvalent, Inc. (NUVL) has delivered an average annual return of +46.85% with a median return of +28.50%. The compound annual growth rate (CAGR) is +38.33%. The stock posted gains in 4 years (80%) and losses in 1 years (20%).
NUVL's best year was 2023 with a +147.11% gain, while the worst was 2026 at -4.14%. The longest streak of consecutive positive years was 4, and the longest losing streak was 1 years. NUVL achieved double-digit gains (10%+) in 3 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -4.14% | $100.59 | $96.43 |
| 2025 | +28.50% | $78.28 | $100.59 |
| 2024 | +6.37% | $73.59 | $78.28 |
| 2023 | +147.11% | $29.78 | $73.59 |
| 2022 | +56.41% | $19.04 | $29.78 |
Frequently Asked Questions: NUVL
What sector is NUVL in? ▼
NUVL operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has NUVL performed historically? ▼
Over 5 years of trading history, NUVL has posted gains in 4 years (80% of the time). The best year was 2023 with a +147.1% return. Past performance does not guarantee future results.
How can I invest in NUVL? ▼
You can invest in NUVL through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold NUVL.
Last updated: 3/24/2026